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PRODUCTION OF FUNCTIONAL PROTEINS
BALANCE OF SHEAR STRESS AND
GRAVITY
CLAIM OF BENEFIT OF PRIORITY OF
PRIOR-FILED CO-PENDING
NON-PROVISIONAL APPLICATION
This application is a continuation of commonly-owned
U.S. patent application Ser. No. 10/947,786, filed Sep. 20,
2004, which is a continuation of U.S. application Ser. No.
09/532,001, filed Mar. 21, 2000, now U.S. Pat. No. 6,946,246,
which is a divisional of U.S. application Ser. No. 09/056,363,
filedApr. 7, 1998, now U.S. Pat. No. 6,730,498, which claims
the benefit of provisional U.S. Application Ser. No. 60/043,
205, filed Apr. 8, 1997.
CROSS-REFERENCE TO RELATED
APPLICATIONS
This application is related to U.S. patent application Ser.
No. 10/734,759 filed Dec. 11, 2003, now U.S. Pat. No. 7,198,
947.
ORIGIN OF THE INVENTION
The present invention was funded by NIH Grant DK46117,
NIH R21, and NASA NRA Grant 9-811. Consequently, the
United States government has certain rights in this invention.
The jointly made invention described herein was made by
an employee of the United States Government and may be
manufactured and used by or for the Government of the
United States of America for governmental purposes without
the payment of any royalties hereon or therefor.
The invention described herein was also made by inventors
in the performance of work under an agreement with Tulane
Educational Fund and is subject to the provisions of Section
305 of the National Aeronautics and Space Act of 1958,
Public Law 85-568 (72 Star. 435; 42 U.S.C. §2457).
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of
protein chemistry, endocrinology and gene therapy. More
specifically, the present invention relates to a method for
production of functional proteins in culture in response to
shear stress using a rotating wall vessel.
2. Description of the Related Art
A successful and documented modality to induce polariza-
tion and differentiation of cells in culture is the rotating wall
vessel (References Cited Nos. 1-4 (hereinafter referred to
simply by number)). In rotating wall vessels, gravity is bal-
anced by equal and opposite physical forces including shear
stresses. In engineering terms, this balance has been claimed
to simulate microgravity at boundary conditions [Wolf D. A.
and R. P. Schwarz. (1991) NASA Technical Paper 3143].
Rotating wall vessels, including models wirhperfusion, are
a quantum advance. The rotating wall vessel is a horizontally
rotated cylindrical cell culture device with a coaxial tubular
oxygenator (1, 5-7). The rotating wall vessel induces expres-
sion of select tissue-specific proteins in diverse cell cultures
(1, 2, 8, and 9). Examples of expression of tissue-specific
proteins include carcinoembryonic antigen expression in
MIP-101 colon carcinoma cells (2), prostate specific antigen
induction in human prostate fibroblasts (7), through matrix
material induction during chondrocyte culture (8). The qui-
2
escent cell culture environment of the rotating wall vessel
balances gravity with shear and other forces without obvious
mass transfer tradeoff (1, 2, and 4). The rotating wall vessel
provides a culture environment suitable for co-cultures of
5 diverse cell types and for formation of three-dimensional
tissue constructs.
Rotating wall vessel technology is being used in clinical
medical practice recently by facilitating pancreatic islet
implantation (4, 10). Pancreatic islets are prepared in rotating
l0 
wall vessels to maintain production and regulation of insulin
secretion. The islets are alginate encapsulated to create a
non-inflammatory immune haven and are implanted into the
peritoneal cavity of Type I diabetic patients. This implanta-
15 tion of pancreatic islets has maintained normoglycemia for 18
months in diabetic patients and progressed to Phase III clini-
cal trials (4, 10). The rotating wall vessels have also been
applied to, for example, mammalian skeletal muscle tissue,
cartilage, salivary glands, ovarian tumor cells, and colon
20 crypt cells (11-13). Previous studies on shear stress response
in endothelial cells and rotating wall vessel culture have been
limited to structural genes (14-16). These studies did not
address the issue of a process for the production of functional
molecules, such as hormones. Shear stress response elements
25 have not previously been demonstrated in epithelial cells for
structural genes of production of functional molecules.
Vitamin D dependent rickets has been a disease familiar to
family farms and larger animal husbandry industries for cen-
turies (17 18). The development of renal replacement therapy
3o by dialysis in humans expanded vitamin D deficient bone
disease from an occasional human clinical caveat to a com-
mon clinical problem. This problem led to the identification
of the active form of vitamin D as 1,25-diOH D 3 and the
development of a multi-billion dollar per year worldwide
35 market, predominantly in end-stage renal disease patients, to
provide replacement hormone clinically (18). The active
1,25-diOH form of vitamin D3 is mainly used to treat bone
disease in dialysis patients, but it has also been implicated as
a therapy for osteoporosis and some forms of cancer.
4o Recently, the effects of vitamin D have been recognized to
play a central role not only in other common bone lesions
such as osteoporosis due to aging and steroid induced
osteoporosis, but in immune function and surveillance,
growth and development, and cardiac and skeletal muscle
45 function (19-22).
Several-active forms of vitamin D have been identified,
vitamin D receptors cloned, and nuclear binding proteins for
the hormone identified and cloned (17-22). Studies on the
regulation of 1-a-hydroxylase activity are limited by the lack
50 of a renal cell line with regulated expression of the enzyme.
The only reports of 1-a-hydroxylase activity in culture utilize
freshly isolated chicken renal cortical cells in which the activ-
ity declines precipitously within 48 hours of plating in culture
(28).
55 The importance of the renal I-a-hydroxylaseis best under-
stood by comparing the kinetics of the renal enzyme to other
forms in the body (29-30). Demonstration that nephrectomy
in pregnant rats did not completely abolish 1,25-diOH-D3
formation sparked an intensive search for extrarenal sites of
60 1-a-hydroxylase activity (29). Although 1-a-hydroxylase
activity has been reported in monocytes, liver, aortic endot-
helium and a variety of placental and fetal tissues, the enzyme
kinetics contrast sharply with the renal 1-a-hydroxylase.
Extrarenal l -a-hydroxylase has a much higher Km indicating
65 that much higher substrate levels are needed for activity (29).
In the uremic patient, extrarenal 1,25-diOH D 3 production is
very limited due to a relative lack of substrate. Administrating
US 7,972,821 B2
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large quantities of 25-OH D3 substrate to anephric patients
modestly boosts plasma 1,25-diOH D3 levels (29).
The lack of a differentiated polarized line of renal tubular
epithelial cells for investigative purposes persists despite
extensive searches by several laboratories (31-38). Renally
derived cell lines transformed with viruses or tumor cells to
produce immortality continue as some of the most popular
cell biological tools to study polarized delivery (31, 33, and
35). But these renally derived immortal cell lines such as
MDCK or LLP-CKI retain few if any of the differentiated
features characteristic of renal epithelial cells. Similarly, pri-
mary cultures rapidly dedifferentiate and modalities as
diverse as basement membrane matrices, growth supple-
ments or Millipore inserts achieve only modest degrees of
polarity (37-38).
The pathognomonic structural features of renal proximal
tubular epithelial cells are the abundance of apically derived
microvilli, the glycoprotein content of associated intermi-
crovillar clefts, and the highly distinctive arrangement of
subapical endosomal elements (39-40). Renal epithelial cells
of the proximal tubule are characterized by thousands of long
apical microvilli. The apical endosomal machinery begins in
intermicrovillar clefts. The endosomal pathway is character-
ized by clathrin-coated vesicles, small spherical endosomal
vesicles with deeper larger endosomal vacuoles (33, 39).
From the endosomal vacuoles proteins and lipids either
recycle to apical surface in dense apical tubules or shuttle to
lysosomes to be degraded.
A cluster of apical proteins with homologous sequence
repeats are especially desirable to express in cultured cells as
they are thought to be molecular mediators of renal injury
(41-43). Two of these proteins-megalin (gp330) and cubulin
(gp280) (Moestrup, et al., J. Biol. Chem..beta.273 (9):5325
5242 (1998) are molecular mediators of tubular vacuola-
tion and ensuing secondary damage. Megalin (gp330) is a
receptor found on the luminal surface of the proximal tubular
cells of the kidney. Megalin binds several proteins and drugs
including aminoglycoside antibiotics and other polybasic
drugs. Megalin is expressed in the kidney, lung, testes, ear,
and placenta. The only cells previously known to express
megalin in culture are immortalized placental cells. There is
no known renal cell culture which expresses megalin. Cubu-
lin (gp280) is a receptor found on the luminal surface of the
proximal tubular cells of the kidney. Gp280 binds several
proteins and drugs including intrinsic factor-cobalamin (vita-
min B12 bound to its carrier protein) and myeloma light
chains. Cubulin (gp280) is expressed in the kidney, ear, and
placenta. The only cells previously known to express cubulin
(gp280) in culture are immortalized placental cells. There is
no known renal cell culture which expresses cubulin (gp280).
Erythropoietin (EPO) is a hormone produced in the kidney
and secreted into the blood. Erythropoietin controls the rate of
production of red blood cells by the bone marrow. Erythro-
poietin may be produced by the interstitial cells between the
tubules or the proximal tubular cells or both. Erythropoietin
production is lost in all known renal cell culture systems.
Erythropoietin is mainly used to treat anemia in dialysis
patients but is also popular to treat the anemia of AIDS
patients and many forms of cancer.
The prior art is deficient in the lack of effective means of
producing functional proteins including hormones in
response to shear stress. Further, theprior art is deficient in the
identification of shear stress response elements in epithelial
cell genes. The present invention fulfills this longstanding
need and desire in the art.
SUMMARY OF THE INVENTION
In one embodiment of the present invention, a method of
producing a functional protein comprises the steps of: isolat-
4
ing mammalian cells; placing said cells into a rotating wall
vessel containing a cell culture comprising culture media and
culture matrix; producing three-dimensional cell aggregates
under simulated microgravity conditions; and detecting
5 expression of the functional protein in the cell culture.
In another embodiment of the present invention, a method
of inducing expression of at least one gene in a cell comprises
the steps of: contacting said cell with a transcription factor
decoy oligonucleotide sequence directed against a nucleotide
10 sequence encoding a shear stress response element; and deter-
mining the expression of said gene in said cell.
In yet another embodiment of the present invention, a
transcription factor decoy comprises an oligonucleotide
sequence directed against a nucleotide sequence encoding a
15 shear stress response element.
Other and further aspects, features, and advantages of the
present invention will be apparent from the following descrip-
tion of the exemplary embodiments of the invention given for
the purpose of disclosure.
20
BRIEF DESCRIPTION OF THE DRAWINGS
More particular descriptions of the exemplary embodi-
ments of the invention briefly summarized above may be had
25 by reference to illustrations thereof in the appended drawings.
These drawings form a part of the specification. The
appended drawings illustrate exemplary embodiments of the
invention and therefore are not to be considered limiting in
their scope.
30 FIGS. 1A-1D show homogeneity and structure of human
renal epithelial cells in culture. Flow cytometry frequency
histograms demonstrate number of cells positive for the
proximal tubular marker gamma-glutamyl transferase. FIG.
1A shows the number of cells with gamma-glutamyl trans-
35 ferase activity as the frequency of activity in 2000 cells com-
pared to an unstained control with trapping agent alone. This
is the raw digest of human renal cells. FIG. 1B shows that
following differential trypsinization, the percentage ofproxi-
mal tubular cells present can be increased to 99±I%. FIGS.
40 1C and 1D show transmission electron micrographs of human
epithelial cells in culture. The intact renal cortex in vivo (far
left panel), is compared to culture of the natural mixture of
human renal cortical cells in conventional 2-dimensional cul-
ture (middle left panel) which is completely devoid of
45 microvilli. Rotating wall vessel culture of pure proximal
tubular cells shows some microvilli (middle right panel), but
there are far more microvilli during rotating wall vessel cul-
ture of the natural mix of renal cortical cells (far right panel).
Compared to these representative images, some areas of the
5o natural mixture of cells in the rotating wall vessel show much
greater abundance of microvilli and well-defined desmo-
somes (lower panel) which are lacking in the other cultures.
FIGS. 2A-2E show protein expression in the rotating wall
vessel. FIGS. 2A-2C show analysis of the expression and
55 endosomal compartmentation of megalin and cubulin in renal
cells following rotating wall vessel culture. The ability of flow
cytometry to make simultaneous measurements of entrapped
fluorescein dextran as an endosomal marker and antibody
binding allows construction of three-dimensional frequency
6o histograms displaying entrapped fluorescein dextran fluores-
cence against antibody binding on horizontal axes. A control
sample shows vesicles negative for fluorescein on the left and
fluorescein containing endosomes on the right (2000 vesicles
depicted left panel). A control without fluorescein entrapped
65 shows only the left population (not shown). Co-localization
of anti-cubulin binding demonstrates that all the fluorescein
positive endosomes are positive for cubulin, while non-endo-
US 7,972,821 B2
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somal membranes can be subdivided into cubulin positive and
negative populations (middle panel). This pattern is repeated
for anti-megalin binding in renal cortical cells (right panel).
FIG. 2D shows quantization of cubulin and megalin anti-
body binding to renal cell membranes under various culture 5
conditions. Analysis of protein expression in cultured cells by
antibody binding used classic serial log dilution antibody
curves. An increase in binding with a decrease in dilution is
pathognomonic for specific antibody binding during flow
cytometry analysis. Binding of anti-cubulin antisera to mem- io
brane vesicles prepared from renal cortical cells after 16 days
in culture, detected by the fluorescence of a phycoerthyrein
tagged secondary antibody, shows an almost two log increase
in binding with antibody dilution (upper left panel below).
This increased cubulin antibody binding in the cells grown in 15
the slow-turning lateral vessel (STLV) is more than five times
the expression seen in stirred fermentors. Similarly, there was
no detectable expression in the conventional cultures result-
ing in a flat line (not shown). Binding of normal serum and
minimal dilution of primary antisera were not delectably 20
different. Binding curves for anti-megalin antiserum showed
a similar pattern (not shown).
FIG. 2E depicts non-specific (minimum) and peak binding
of each antiserum following rotating wall vessel culture and
two-dimensional SDS-PAGE analysis of protein content of 25
cells following rotating wall vessel culture. Analysis of the
protein content of cultures of the natural mixture of rat renal
cortical cells after 16 days culture in gas permeable bags as a
control (left panel) or rotating wall vessel (right panel) depicts
changes in a select set of proteins. Molecular weight (14 220 30
kDa) on the abscissa is displayed against isoelectric point (pH
3-10) on the ordinate.
FIGS. 3A-3D show gene expression in the rotating wall
vessel. FIG. 3A and FIG. 3B show differential display of
genetic expression of rat renal cortical cells grown in conven- 35
tional culture or rotating wall vessels. Differential display of
expressed genes was compared in aliquots of the same cells
grown in a 55 ml rotating wall vessel (STLV) or conventional
gas permeable 2-dimensional bag controls. For differential
display, copies of expressed genes were generated by poly- 40
merase chain reaction using random 25 mer primers and
separated on a 6% DNA sequencing gel (FIG. 3A). Bands of
different intensity between control and STLV, representing
differentially expressed genes, were identified by visual
inspection, excised, and reamplified using the same primers. 45
Differential expression and transcript size were confirmed by
Northern hybridization (FIG. 313). PCR products were then
subcloned into the pGEM-T vector and sequenced.
Sequences were compared to the Genebank sequences using
the BLAST search engine. One expressed gene which 50
decreased in the STLV (band D on gel above) was identified
as rat manganese-containing superoxide dysmutase (98%
match 142 of 144 nucleotides). Two genes increased in the
STLV: Band A was identified as the interleukin-1 beta gene
(100% match for 32 of 32 nucleotides) and Band B, which 55
corresponded to a 20 kB transcript on a Northern blot,
appeared to be a unidentified gene that has a 76% homology
to the mouse GABA transporter gene. FIG. 3C and FIG. 3D
show RT-PCR of time dependent change in genes during
rotating wall vessel culture. Semi quantitative RT-PCR shows 60
increases in the epithelial genes megalin, villin and extra-
cellular calcium sensing receptor (ECaR), the shear stress
response element genes ICAM, VCAM, and MnSOD (FIG.
3C). There was no change in b-actin or GADPH. Unlike in
endothelial cells, many of these changes are prolonged, as at 65
16 days megalin, ECaR, ICAM, VCAM and villin changes
persist (FIG. 3D).
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FIGS. 4A-4C show structure and effects of an antisense
probe for shear stress response element on rat renal cortical
epithelial cells. FIG. 4A shows the structure. The probe with
sequence CTGAGACCGATATCGGTCTCAG (SEQ ID
No: 1) has two possible conformations. As a single strand it
would fold back on itself to form a binding element for the
transcription factor. As a double strand it would then have two
binding sites for the transcription factor, one in the sense
orientation and one in the antisense orientation.
FIGS. 4B and 4C show effects of an antisense shear stress
response element probe on time dependent gene expression.
The antisense probe added to conventional 2-dimensional
cultures of rat renal cortical cells at 80 mn increases MnSOD
in a time dependent manner. Comparison is made to controls
with the active binding site scrambled. In contrast the probe
has no effect on villin gene expression.
FIG. 5 shows gene expression in the rotating wall vessel via
automated gene analysis. Abundance of the expression of
over 18,300 genes was assayed by annealing poly A RNA
from human renal cortical epithelial cells grown in a rotating
wall vessel for 8 days to a filter robotically loaded with
oligonucleotide primers. Poly A RNA from a non-adherent
bag culture serves as a control. The filters are shown at the top
of the diagram, then the analysis of shear stress responsive
genes, renal epithelium specific genes, and other genes ger-
mane to the current analysis.
DETAILED DESCRIPTION OF THE
EXEMPLARY EMBODIMENTS
An exemplary embodiment of the present invention is
directed to a method of producing a functional protein, com-
prising the steps of: isolating mammalian cells; placing said
cells into a rotating wall vessel containing a cell culture
comprising culture media and culture matrix; producing
three-dimensional cell aggregates under simulated micro-
gravity conditions; and detecting expression of the functional
protein in the cell culture. Generally, simulated microgravity
conditions comprise a balance between gravity and oppo-
sitely directed physical forces. Representative examples of
such physical forces include sedimentational shear stress,
centrifugal forces, viscosity and Coriolis forces.
In one embodiment, the functional protein is selected from
the group consisting of a hormone, a toxin receptor, and a
shear stress dependent functional biomolecule. Representa-
tive examples of hormones which can be produced according
to the exemplary method include 1,25-dihydroxy-vitamin D3
and erythropoietin. Representative examples of toxin recep-
tors which can be produced according to the exemplary
method include megalin and cubulin. Representative
examples of shear stress dependent functional biomolecules
which can be produced according to the exemplary method
include biomolecules selected from the group consisting of
villin, magnesium dependent superoxide dismutase, nitric
oxide synthase, c-fos, c-jun, platelet derived growth factor-b,
transforming growth factor-b, tissue-type plasminogen acti-
vator and monocyte chemotactic protein-1, megalin, cubulin,
erythropoietin and 1-a-hydroxylase.
Generally, any mammalian cell could be used in the exem-
plary methods of the present invention. Representative
examples of mammalian cells include renal cortical cells,
renal fibroblast cells, hepatocytes, pancreatic islets, renal
interstitial cells, parathyroid cells, thyroid cells, pituitary
cells, ovarian cells and testicular cells. Generally, the cell is
selected from the group consisting of epithelial cells and
endothelial cells. Preferably, the cell that is selected contains
US 7,972,821 B2
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shear stress response elements. Representative examples of
shear stress response elements include GAGACC and
GGTCTC.
In the methods of the exemplary embodiments, the rotating
wall vessel is initiated and maintained from about 6 rotations 5
per minute to about 16 rotations per minute. Preferably, the
sedimentational shear stress is from about 0.2 dynes/cm2 to
about 1.0 dynes/cm 2 . The culture matrix may contain a core
structure selected from the group consisting of cell aggregates
and microcarrier beads, although other components to such a l0
culture matrix are well known to those having ordinary skill
in this art.
Another exemplary embodiment described herein is
directed to a method of inducing expression of at least one 15
gene in a cell, comprising the steps of. contacting said cell
with an transcription factor decoy oligonucleotide sequence
directed against a nucleotide sequence encoding a shear stress
response element; and determining the expression of said
gene in said cell. Generally, an oligonucleotide comprises a 20
terminal phosphothiorate moiety and a phosphodiester back-
bone and a structure which allows the oligonucleotide to pass
cell membranes and accumulate in the nuclear compartment
of the cell. Generally, the cell is a cultured cell. In one
embodiment, the cell is selected from the group consisting of 25
an epithelial cell and an endothelial cell. Representative
examples of a type of cell which can be used in this method
include a renal cortical cell, renal fibroblast cell, hepatocyte,
pancreatic islet, renal interstitial cell, parathyroid cell, thyroid
cell, pituitary cell, ovarian cell and testicular cell. In one 30
embodiment, the cell is grown in two-dimensional culture.
Representative examples of shear stress response elements
include GAGACC and GGTCTC. Preferably, the gene
encodes a protein selected from the group consisting of mega-
lin, cubulin, erythropoietin and 1-a-hydroxylase. The con- 35
centration of the oligonucleotide useful in this method gen-
erally ranges from about 10 nM to about 10 mM.
Another exemplary embodiment of the present invention is
directed to a transcription factor decoy comprising an oligo-
nucleotide sequence directed against a nucleotide sequence 40
encoding a shear stress response element. Preferably, the
nucleotide sequence encoding a shear stress response element
has a sequence selected from the group consisting of
GAGACC and GGTCTC.
In one embodiment, the rotating wall vessel is generally 45
initiated and maintained at 10 rotations per minute. Prefer-
ably, the rotating wall vessel provides a balance of forces
comprising gravity and equal and opposite sedimentational
shear stress. Useful sedimentational shear stress rates within
the context of the claimed methods are from about 0.2 dynes/ 50
cm2 to 1.0 dynes/cm2.
As used herein, "rotating wall vessel"refers to a cylindrical
horizontal rotating culture vessel with a coaxial oxygenator.
As used herein, "shear stress response element" refers to a
sequence of a family of genes in the cell nucleus which binds 55
one or more transcription factors in response to shear stress on
the cell. A representative example of a shear stress response
element is GAGACC or its complementary sequence
GGTCTC.
As used herein, "shear stress conditions" refers to flow of 60
liquid, or current of liquid, over cells which causes genes to
turn on or off.
As used herein, "slow turning lateral vessel' or "STLV"
refers to one specific size and shape of a rotating wall vessel.
As used herein, "differential display" refers to displaying 65
on a filter, gel or chip a discrete set of genes turned on or off
in a cell under two different conditions.
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As used herein, "simulated microgravity" refers to balance
of gravity by oppositely directed forces including shear
stresses during rotational wall vessel culture.
As used herein, "graded gravitational sedimentation shear"
refers to the shear imparted to a particle or cell falling through
fluid.
As used herein, "functional protein" refers to a protein with
biological effects.
As used herein, "three-dimensional culture process" refers
to cells grown in a matrix or on beads (or other three-dimen-
sional structural support) in a three-dimensional array, rather
than on a flat plate.
As used herein, "Coriolis force" refers to an incidental flow
field caused by the rotating gravity vector in the rotating wall
vessel.
As used herein, "shear stress" refers to the force felt at the
surface of the particle as it moves through the fluid.
As used herein, "gravity-induced sedimentation" refers to
the force on a particle in the rotating wall vessel making it fall
through the fluid due to gravity.
As used herein, "centrifugal force" refers to the force on a
particle in the rotating wall vessel which pulls it towards the
wall due to rotational speed.
As used herein, "transcription factor decoy" refers to an
oligonucleotide folded to form a double stranded DNA which
binds a nuclear transcription factor. The transcription factor
decoy prevents the transcription factor from binding pro-
moter regions regulating expression of specific genes.
The following examples are given for the purpose of illus-
trating various embodiments of the invention and are not
meant to limit the present invention in any fashion.
Example 1
Human Renal Cortical Cells
Human renal cortical cells were isolated by Clonetics Inc.
(San Diego, Calif.) from kidneys unsuitable for transplanta-
tion. Differential trypsinization resulted in cell fractions
highly purified for proximal tubular cells compared to the
natural mixture of cells in the renal cortex. The co-culture of
the natural cell mix, and highly purified proximal tubular cells
were cultured separately in a special growth medium with 2%
fetal calf serum.
Example 2
Rat Renal Cortical Cells
Rat renal cells were isolated from renal cortex harvested
from euthanized Sprague Dawley rats (Harlan Sprague-Daw-
ley, Cleveland Ohio) as described (44). In brief, a renal cortex
was dissected out with scissors, minced finely in a renal cell
buffer 137 mmol NaCl, 5.4 mmol KCl, 2.8 mmol CaC12, 1.2
mmol MgC12, 10 mmol HEPES-Tris, pH 7.4. The minced
tissue was placed in 10 ml of a solution of 0.1% Type IV
collagenase and 0.1% trypsin in normal saline. The solution
was incubated in a 37° C. shaking water bath for 45 minutes
with intermittent titration. The cells were spun gently (800
rpm for 5 minutes), the supernatant aspirated, the cells resus-
pended in 5 ml renal cell buffer with 0.1 % bovine serum, and
passed through a fine (70 mm) mesh. The fraction passing
through the mesh was layered over a discontinuous gradient
of 5% bovine serum albumin and spun gently. The superna-
tant was again discarded. The cells were resuspended in
US 7,972,821 B2
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DMEM/F-12 medium (ciprofloxacin and fungizone treated)
and placed into culture in various culture vessels in a 5% COz,
95% 02 incubator.
Example 3
Culture Techniques: Rotating Wall Vessels
When grown under conventional conditions in DMEM/
F12 supplemented with fetal calf serum and an antibiotic
cocktail such as ciprofloxacin and fungizone, both the highly
purified cells as well as the cell mix form a monolayer. Fetal
calf serum was used at optimal concentration: 2% for human
calls and 10% for rat cells. In order to increase epithelial cell
differentiation (1, 45), renal cells were cultured in a rotating
wall vessel known as a 55 ml slow turning lateral vessel
(STLV) (1, 45). To initiate cell culture, the slow turning lateral
vessel was filled with medium and seeded by addition of cell
suspension (2x106 cells/ml). Residual air was removed
through a syringe port and vessel rotation was initiated at 10
rotations per minute and maintained for 10-16 days. Medium
was changed every 2 to 3 days depending on glucose utiliza-
tion. Concomitant with cells, microcarrier beads were added
an 5 mg/ml to promote aggregate formation in the slow turn-
ing lateral vessel. Without beads the cells became shattered in
the vessel in a few hours. Beads were Cytodex-3 in all pro-
tocol except when electron microscopy was planned, when
the much more expensive but easily sectioned Cultisphere GL
cells were added to the vessels.
Example 4
Stirred Controls and Static Controls
To provide a stirred control stirred fermentors whichmixed
in the horizontal plane were loaded with identical concentra-
tions of cells and beads from the same pool added to the slow
turning lateral vessel (1, 31, and 46). Gas permeable Fluoro-
seal bags (Fluoroseal Inc, Urbana Ill.) in 7 or 55 ml size were
selected as conventional static controls. Culture beads were
added to the conventional controls at the same density as the
slow turning lateral vessel cultures (1, 45).
Example 5
Electron Microscopy Quantization of Number of
Microvilli
Transmission electron micrographs were performed on
cell aggregates from the rotating wall vessels and conven-
tional monolayers. Cells were washed with ice cold phos-
phate buffered saline, then fixed for electron microscopy with
2.5% glutaraldehyde in phosphate buffered saline (9, 47). The
samples were then transferred to 1 % osmium tetroxide in 0.05
M sodium phosphate (pH 7.2) for several hours, dehydrated
in an acetone series followed by embedding in Epon. Lead-
stained thin sections were examined and photographed using
a Phillips EM/200 electron microscope. For electron micros-
copy the easily sectioned Cultisphere GL beads replaced
Cytodex-3 beads, which are almost impossible to section.
Example 6
Analysis of the Proximal Tubule Epithelial Marker,
y-glutamyl Transpeptidase
The renal cortical cells were 75±4% (n=4) proximal
tubules as determined by flow cytometry analysis of aliquots
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for the proximal marker y-glutamyl transferase using Schiff
base trapping of cleavage products of L-y-glu-4-methoxy-4-
P-naphthylamine (44) (FIGS. 1A-113).
5	 Example 7
Analysis of the Endosomal Distribution of Megalin
and Cubulin by Flow Cytometry
10 To quantify the total and endosomal expression of cubulin,
megalin, and aquaporin-2 cells in conventional culture,
stirred fermentors, and slow turning lateral vessels, 0.3 mg/ml
I OS fluorescein-dextran was added to each cell culture for 10
15 minutes at 37° C. in the COz incubator. This step loads an
entrapped fluorescent dye into the early endosomal pathway
(9, 47). Cells were then immediately diluted into ice cold
phosphate buffered saline and washed once. Next, the cells
were homogenized with 6 passes of a tight fitting glass-Teflon
20 motor driven homogenizer. A post-nuclear supernatant was
formed as the 11,000 g supernatant, 180,000 g pellet of mem-
brane vessels (FIGS. 2A-2C).
Aliquots of membrane vesicles were labeled with megalin
or cubulin antisera. The megalin and cubulin antisera were
25 rabbit polyclonals raised to affinity purified and chromato-
graphically pure receptor (43, 48). Membrane vesicles were
first pre-incubated in 50% normal goat serum for 2 hours to
reduce non-specific binding of secondary antisera raised in
goat. After washing aliquots of membrane vesicles were
30 stained with serial log dilution of antisera and incubated at 4°
C. overnight. After further washing, 1:40 of goat anti-rabbit
affinity purified rat pre-absorbed phycoerthyrein conjugated
secondary antiserum was added, and incubated for 4 hours at
room temperature. Prior to flow cytometry, the membrane
35 vesicles were washed and resuspended in 200 mM mannitol,
100 mM KCl, 10 mM HEPES, pH 8.0 with Tris to which had
been added 10 mM nigericin. In the presence of potassium,
nigericin collapses pH gradients, ensuring optimal fluores-
cence of the highly pH dependent fluorescein-dextran emis-
40 Sion. Fluorescein-dextran and antibody staining tagged by
phycoerythrein were now analyzed and co-localized on a
vesicle-by-vesicle basis by flow cytometry (FIGS. 2A-2C).
Example 8
45
Differential Display
Differential display of expressed genes was compared in
aliquots of the same cells grown in a 55 ml rotating wall vessel
50 (slow turning lateral vessel) or conventional gas permeable
2-dimensional bag controls (FIGS. 3A and 313). Differential
display was performed using Delta RNA Fingerprinting sys-
tem (Clontech labs, Palo Alto Calif.). Copies of expressed
genes were generated by polymerase chain reaction using
55 random 25 merprimers and separated on a 6% DNA sequenc-
ing gel. Bands of different intensity between control and slow
turning lateral vessel, representing differentially expressed
genes, were identified by visual inspection, excised and ream-
plified using the same primers. Differential expression and
60 transcript size were confirmed by Northern hybridization.
PCR products were then subcloned into the pGEM-T vector
(Promega, Madison Wis.) and sequenced using fMOL cycle
sequencing system (Promega, Madison, Wis.). Sequences
were compared to the Genebank sequences using the BLAST
65 search engine (ational Center for Biotechnology Informa-
tion). For genes of interest the bands were labeled with 32P
for confirmation of the changes by Northern blot analysis.
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Cell aggregates from the rotating wall vessel culture were
washed once in ice cold phosphate buffered saline and snap
frozen at —70'C. until RNA was isolated. Total RNA was first
isolated, followed by isolation of poly A+ RNA. Following
reverse transcription, 10%-20% of each cDNA was amplified
(Robocycler 40, Stratagene, La Jolla, Calif.) using 95° C.
denaturation, 63° C. annealing and 72° C. extension tempera-
tures. Amplification was for a total of 30 cycles with the first
three cycles having extended denaturation and annealing
times. Positive and negative strand PCR primers, respec-
tively, were derived from published sequences using Gene-
tunner software. Twenty percent (20%) of the PCR reaction
was electrophoresed on agarose/ethidium bromide gels and
visualized under UV light so that a comparison of amplified
gene fragments could be made to DNA standards (HaeIII
digested X174 DNA, Promega) electrophoresed on the same
gel (FIGS. 3C and 3D). Representative fragments amplified
for each gene in question were isolated from gels and direct
sequenced to assure identity of the PCR product. In addition,
5% of the same cDNA were subjected to PCR for expression
of the housekeeping mRNA, glyceraldehyde 3-phosphate
dehydrogenase, and b-actin to assure that similar amounts of
input RNA and that similar efficiencies of reverse transcrip-
tion were being compared. Each cDNA was run in at least
three dilutions to ensure that measurements were made on the
initial linear portion of the response curve.
Example 10
Genetic Decoys
Double stranded genetic decoys matching the sequence of
a known shear stress response element were synthesized
(Chemicon International Inc., La Jolla, Calif.) (structure and
sequence shown in FIG. 4A). These decoys had a terminal
phosphothiorate moiety to prevent intracellular lysis and a
phosphodiester backbone to facilitate passage across cell
membranes (49). Passage to and accumulation in the nuclear
compartment of cultured cells was confirmed by confocal
imaging of a fluorescein tagged decoy. Three decoys were
synthesized: the active decoy, a random sequence control in
which the six bases of the shear stress response element were
scrambled, and a fluorescein conjugated form of the decoy.
Decoys were placed in the cell culture medium of rat renal
cortical cells grown as above in conventional two-dimen-
sional culture. Aliquots of cells exposed to control or active
sequence decoy at 80 nm concentration were harvested at 2, 6,
and 24 hours after exposure.
Example 11
Genetic Discovery Array
A sample of human renal cortical cells grown in conven-
tional flask culture was trypsinized and split into a gas per-
meable bag control and a rotating wall vessel (55 ml slow
turning lateral vessel). After 8 days of culture on 5 mg/ml
cytodex-3 beads, cells were washed once with ice cold phos-
phate buffered saline, the cells were then lysed and mRNA
was selected with biotinylated oligo(dT) then separated with
streptavidin paramagnetic particles (PolyATract System
1000, Promega Madison, Wis.). 32P labeled cDNA probes
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were then generated by reverse transcription with 32P dCTP.
The cDNA probes were hybridized to identical Gene Discov-
ery Array Filters (Genome Systems Inc. St. Louis, Mo.). The
Gene Discovery Array filters contain 18,394 unique human
5 genes from the I.M.A.G.E. Consortium [LLNL](15) cDNA
Libraries which are robotically arrayed on each of a pair of
filter membranes. Gene expression was then detected by
phosphor imaging and analyzed using the Gene Discovery
Software [Genome Systems] (50).
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Example 12
Assay of 1-a-hydroxylaseActivity
15 As the 1-a-hydroxylase enzyme has never been isolated or
cloned, it is assayed functionally by the production of 1,25-
dihydroxy-vitamin D 3 from ultrapure exogenous 25-hydroxy
vitamin D3 . For each measurement, the classic Michaelis
Menton kinetics of the enzyme are determined by assaying
20 equal aliquots of renal cell aggregates in a curve of 25-OH D3
substrate concentrations from 0.1 to 10 mg/ml in 6 steps. All
incubations are performed in the presence of the anti-oxidant
DPED at 10 mM to ensure no contribution of non-enzymatic
oxygenation (23-26). 1,25-diOH D 3 generated in vitro was
25 quantified as described (23-27). In vitro B incubations were
terminated by adding a volume of acetonitrile equal to the
incubation volume. Each incubation tube received 1,000 cpm
of 3 H-1,25 dihydroxy D3 to estimate recovery losses during
the extensive extraction and purification scheme. The 1,25-
30 dihydroxy D3 is extracted from the incubation medium by
C18 solid-phase extraction (24-25). Following extraction, the
samples are evaporated to dryness under N z and dissolved in
2 ml of methylene chloride. The samples are then applied to
silica Bond-Slut cartridges and the 1,25-dihydroxy D 3 -con-
35 taining fraction is isolated and collected (26). The individual
fractions containing 1,25-diOH D3 are then subjected to nor-
mal phase HPLC on a Beckman model 344 liquid chroma-
tography system. Normal-phase HPLC was performed with a
Zorbax-Sil column (26) (4x25 cm) developed in and eluted
40 with methylene chloride/isopropanol (96:4 v/v) with a flow
rate of 2 mL/min. The 1,25-dihydroxy D 3 eluted from this
system was dried under N 2 resuspended in ethanol and
counted by radio receptor assay or radio immunoassay (25-
26). Plasma 1-25-dihydroxy vitamin D 3 was assayed in a
45 similar fashion, but as the product is already formed, assay
begins with extraction into acetonitrile (23-26). Hence, all
measurement of 1-a-hydroxylase activity in cells included
determination of the Michaelis Menton Km and Vmax of the
enzyme. The Michaelis Menton parameters were determined
50 by automated curve fitting.
Example 13
Culturing Renal Fibroblasts and Assay for
55	 Production of Erythropoietin
As renal fibroblasts are the source of erythropoietin
secreted into the circulation, renal fibroblasts were cultured.
Freshly dissected rat renal cortex was minced and
60 collagenase\trypsin digested prior to removal of debris on a
single discontinuous 5% albumin gradient. The mixture of rat
renal cortical cells was placed into culture in DMEMA 2 with
20% fetal bovine serum. After two weeks to encourage fibro-
blast overgrowth in the rich medium, fibroblast growth factor
65 was added. The resultant culture had fibroblastic features in
the culture flask and was inoculated into a high aspect rotating
vessel (HARV) for culture under increased shear stress con-
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Example 9
Detection of Gene Expression in Cell Cultures by
RT-PCR
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ditions. The cells aggregated on the beads and slowly
increased their numbers. After three (3) weeks growing the
fibroblasts in an HARV, erythropoietin was assayed in the cell
supernatant. The media were concentrated 15 times and
assayed via RIA. The media alone was also concentrated 15
times as the control.
Example 14
Culturing Hepatocytes and Assay for Production of
Erythropoietin
14
microvilli per field; "pure" proximal tubular culture in rotat-
ing wall vessel has 104 microvilli per field; and the normal
cortical cell mix in rotating wall vessel has 3511 microvilli
per field.
5
TABLE 1
Human proximal tubular cells microvilli counted
on transmission electron-micrographs of cells grown
for 16 days under various culture conditions
10
Proximal Tubular	 Microvilli Per
Culture Conditions	 Markers	 Field
As hepatocytes are a source of erythropoietin secreted into
the circulation, immortalized human hepatocytes were cul-
tured under control and subjected to shear stress conditions.
The Hep3B cells were placed into culture in DMEM with
10% fetal bovine serum in a static flask culture. The resultant
culture was split, one half remaining in static flask culture and
the other half inoculated into an HARV for culture under
increased shear stress conditions. The cells aggregated on the
beads. After 24 hours of growing the Hep3B cells in an
HARV, erythropoietin was assayed in the cell supernatant.
The media were assayed by RIA. The static flask media was
also assayed as the control.
Example 15
Shear Stress Response Elements Mediate Changes in
Erythropoietin Gene Expression
The immortal hepatic cell line, Hep3B, constitutively pro-
duces erythropoietin. The 5' promoter and 3' enhancer regions
of the gene contain putative shear stress response elements.
The role of these elements in the enhancement of erythropoi-
etin production in response to shear was tested by using an
integrated perfused rotating wall vessel culture to reintroduce
graded shear. This protocol utilizes a library of promoters
driving luciferase reporter genes, with various constructs
lacking the putative shear stress response elements. It also
allows DNA footprinting analysis of the histones which bind
the promoter and enhancer elements.
Results
The proportion of proximal tubular cells in human renal
cell fractions isolated by differential trypsinization was
assayed using an entrapped fluogenic substrate for the proxi-
mal enzyme marker y-glutamyl-transferase (44). Flow
cytometry analysis on a cell-by-cell basis showed the natural
cell mixture in the human renal cortex to be 85±4%, n=4
proximal tubular cells (FIG. 1A, left panel). Following dif-
ferential trypsinization, and selection of the pure fractions,
proximal tubular enrichments as high as 99±1% could be
achieved (right panel). As reported in other systems, rotating
wall vessels were conducive to vigorous cell growth, as evi-
denced by the high rates of glucose consumption assayed as
30 mg/dl glucose/100,000 cells/day. A cell doubling time of
4±3 days was assayed using Alamar blue in the rotating wall
vessel compared to 4±2 days in conventional culture (n=4).
The ultrastructure of cultures of pure proximal tubular cells
or renal cortical cell mixtures of human kidneys were grown
in rotating wall vessels for 16 days, and were examined by
transmission electron microscopy (FIGS. IC and 1D). Quan-
tification of the number of microvilli present by counting
random plates at the same magnification demonstrates not
only that the rotating wall vessel induces microvillus fonna-
tion, but also that co-culture with the normal mix of renal
cortical cells increases the effect (Table 1). Normal cortical
cell mix in conventional two-dimensional culture has 21
Conventional 2-D culture	 85	 21
Pure culture in	 99	 104
15 rotating wall vessel
Normal cortical cell mix	 85	 3511
in rotating wall vessel
To examine the expression of megalin and cubulin in renal
20 cells in culture, there are advantages to using human cells
instead of rat cells. Specifically, the rat sequences of megalin
and cubulin have been cloned, while the human sequences
have not, and the antisera recognizes the rat but not the human
isoforms of these proteins. Hence, the natural mixture of cells
25 in the rat renal cortex was placed into culture in rotating wall
vessels, stirred fermentors, and traditional culture for analysis
of protein expression.
As the endosomal pathway has been implicated to play a
central role in the function and pathophysiology of cubulin
3o and megalin, entrapped endosomal markers were co-local-
ized with receptor antibody binding. The ability of flow
cytometry to make simultaneous measurements of entrapped
fluorescein dextran as an endosomal marker and antibody
binding allows construction of three-dimensional frequency
35 histograms displaying entrapped fluorescein dextran fluores-
cence against antibody binding on horizontal axes and num-
ber of vesicles in each channel up out of the page (FIGS.
2A-2C). A control sample shows vesicles negative for fluo-
rescein on the left and fluorescein containing endosomes on
40 the right (200 vesicles depicted, left panel). A control without
fluorescein entrapped shows only the left population (not
shown). Co-localization of anti-cubulin binding demon-
strates that all the fluorescein positive endosomes were posi-
tive for cubulin, while non-endosomal membranes could be
45 subdivided into cubulin positive and negative populations
(middle panel). This pattern was repeated for anti-megalin
binding in renal cortical cells (right panel) in culture.
Next, analysis of protein expression in cultured cells by
antibody binding used classic serial log dilution antibody
50 curves. An increase in binding with a decrease in dilution is
pathognomonic for specific antibody binding during flow
cytometry analysis. Binding of anti-cubulin antisera to mem-
brane vesicles prepared from renal cortical cells after 16 days
in culture, detected by the fluorescence of a phycoerthyrein
55 tagged secondary antibody, shows an almost two log increase
in binding with antibody dilution (FIG. 2D). This increase in
the cells grown in the rotating wall vessel (slow turning lateral
vessel) is more than five times the expression seen in stirred
fermentors. Similarly, there was no detectable expression in
60 the conventional cultures resulting in a flat line (not shown).
Comparison of maximal binding of the anti-cubulin antibody
to minimum taken to be the antibody dilution at which there
is no further decline in signal with primary antibody dilution
is shown in FIG. 2E. Binding of normal serum and minimal
65 dilution of primary antisera were not detectably different.
Binding curves for anti-megalin antiserum showed a similar
pattern (not shown), but the peak binding was a little lower
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(FIG. 2E). Again, the stirred fermentor has much less expres-
sion than the rotating wall vessel (slow turning lateral vessel)
and the conventional cell membranes have no detectable
binding (not shown).
To examine the proportion of proteins changing in the
rotating wall vessel, two-dimensional gel SDS-PAGE analy-
sis on cultures grown in the rotating wall vessel and bag
controls were performed (FIGS. 3A-3C). The results shown
in FIG. 3C demonstrate changes were in a selected group of
proteins.
To identify the genes changing during rotating wall vessel
culture, differential display was performed. Differential dis-
play of expressed genes was compared in aliquots of the same
cells grown in a 55 ml rotating wall vessel (slow turning
lateral vessel) or conventional gas permeable two-dimen-
sional bag controls. Differential display of copies of
expressed genes were generated by polymerase chain reac-
tion using random 25 mer primers and separated on a 6%
DNA sequencing gel. Bands of different intensity between
control and slow turning lateral vessel, representing differen-
tially expressed genes, were identified by visual inspection,
excised and reamplified using the same primers. Differential
expression and transcript size were confirmed by Northern
hybridization. PCR products were then subcloned into the
pGEM-T vector and sequenced. Sequences were comparedto
the Genebank sequences using the BLAST search engine.
One expressed gene which decreased in the slow turning
lateral vessel (Band D on gel, FIG. 3A) was identified as rat
manganese-containing superoxide dismutase (98% match
142 of 144 nucleotides). Two genes increased in the slow
turning lateral vessel. Band A was identified as the interleu-
kin-I beta gene (100% match for 32 of 32 nucleotides) and
Band B corresponded to a 20 kB transcript on a Northern blot
and appeared to be a unidentified gene that has a 76% homol-
ogy to the mouse GABA transporter gene.
To examine the genetic changes in specific genes, the
expression of tissue specific epithelial cell markers and clas-
sic shear stress response dependent genes were examined by
RT-PCR (FIG. 3C). Several genes specific for renal proximal
tubular epithelial cells, including megalin, cubulin, the extra-
cellular calcium sensing receptor, and the microvillar struc-
tural protein villin, increase early in rotating wall vessel cul-
ture. Similarly, there were dynamic time dependent changes
in classic shear stress dependent genes including intercellular
adhesion molecule I (ICAM) and vascular cell adhesion mol-
ecule (VCAM) (increased) and manganese dependent super-
oxide dismutase (suppressed). Many but not all of these
changes were prolonged, as after 16 days in culture gene
expression of megalin, ICAM, VCAM, and the extracellular
calcium sensing receptor were still elevated, while villin and
manganese dependent superoxide dismutase were at control
levels. Expression of control GADPH, b-actin, and I8S genes
did not change throughout the time course.
To test for a role of a putative endothelial shear stress
response element in these renal cortical cell changes, an anti-
sense probe for the sequence was synthesized (FIG. 4A). A
control probe had the active motif scrambled. Confocal imag-
ing of a fluorescein conjugated form of the probe confirmed
nuclear delivery of the probe (images not shown). Culture of
rat renal cortical cells in 80 nun of the probe resulted in a time
dependent increase in magnesium dependent superoxide dis-
mutase, but no change in villin gene expression (FIGS. 4B
and 4C). The control probe had no effect.
In order to confirm the genetic responses to rotating wall
vessel culture and the analysis with human cells, automated
gene display analysis of expressed RNA was performed on
human renal cortical cells grown in a control gas-permeable
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bag and the slow turning lateral vessel for 8 days. Of the more
than 18,000 genes assayed, a select group was again observed
to change (FIG. 5). In particular, vectored changes in all the
classic shear stress response genes assayed by RT-PCR and
5 differential display in rat cell culture were confirmed. A bat-
tery of tissue specific genes was increased including villin,
angiotensin converting enzyme, parathyroid hormone recep-
tor, and sodium channels. Other physical force dependent
10 
genes such as heat shock proteins 27/28 kDa and 70-2
changed, as did focal adhesion kinase, and a putative tran-
scription factor for shear stress responses NF-kR changed.
Fusion proteins such as synabtobrevin 2 mildly decreased
gene expression, and clathrin light chains hugely increased
15 gene expression.
To determine whether renal cells grown in simulated
microgravity have I -a-hydroxylase activity, the I -a-hy-
droxylase activity of cell cultures were compared grown in
traditional 2-dimensional culture in gas permeable bags, and
20 NASA rotating wall vessels. Both rat renal cells (Table 2) and
human embryonic renal cells were assayed (Table 3).
TABLE 2
25	 The 1-a-hydroxylase activity of the various rat renal
cell cultures detected as production of 1,25-diOH D3
1,25-diOH D3 	Volume of	 1,25-diOH D3
concentration	 Supernatant	 production
30 Cell Sample	 (pg/ml)	 (ml)	 (pg)
Boiled static <2, not detectable 7 ml Not detectable
control I
Boiled static <2, not detectable 7 ml Not detectable
control II35
Static control I <2, not detectable 7 ml Not detectable
Static control II <2, not detectable 7 ml Not detectable
Boiled rotating <2, not detectable 55 ml Not detectable
wall vessel
40 Rotating wall 	 14.2	 55 ml	 781
vessel
The results shown in Table 2 indicate that rat renal cells
45 show increased structural differentiation during culture in
simulated microgravity conditions and express much greater
I-a-hydroxylase activity than under conventional culture
conditions.
50	 TABLE 3
The 1-a-hydroxylase activity of the various human embryonic
renal cell cultures detected as production of 1,25-diOH D,
1,25-diOH D 3 Volume of 1,25-diOH D3
concentration Supernatant production55 Cell Sample	 (pg/ml) (ml) (pg)
Boiled static	 8.2 10 82
control
Static control	 14.6 10 146
Rotating wall	 24.8 55 1364
60	 vessel
Table 3 indicates that human embryonic kidney cells show
increased structural differentiation during culture in simu-
65 lated microgravity conditions and express 10 fold greater
I-a-hydroxylase activity than under conventional culture
conditions.
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TABLE 4
Renal fibroblasts cell supernatant erythropoietin assay
Condition Erythropoietin (mu/ml)
Shear Stress Culture
Control media cone 15X
1.8
0.23
TABLE 5
Hepatocytes cell supernatant erythropoietin assay
Condition Erythropoietin (mu/ml)
Shear stress culture
Control static flask
141.7 mu/1 x 106 cells
undetectable
Results of cell supernatant erythropoietin assay from renal
fibroblasts and hepatocytes culture were shown in Table 4 and
Table 5, respectively. The results shown in Tables 4 and 5
indicate erythropoietin production was increased in both
renal and hepatic cells during graded gravitational sedimen-
tation shear.
Erythropoietin has the classic shear stress response ele-
ments in the promoter and enhancer regions which control
expression of its gene. The results shown in Tables 4 and 5
also indicate that the expression of the erythropoietin gene
was upregulated by those shear stress response elements dur-
ing graded gravitational sedimentation shear in the vessel.
Discussion
Rotating wall vessels have been used by other investigators
as "simulated microgravity". The exemplary embodiments of
the present invention contend that gravity is still active, and
that in a rotating wall vessel gravity is balanced by equal and
opposite sedimentational shear stress. A centrifugal force due
to spinning the cells, quantitatively much smaller than grav-
ity, is also present and offset by equal and opposite sedimen-
tational shear stress. Thus, the present invention presents a
new concept that rotating wall vessels provide this new bal-
ance of forces, including application of sedimentational
shear, rather than microgravity.
The rotating wall vessel bioreactor provides quiescent co-
localization of dissimilar cell types (1, 46), mass transfer rates
that accommodate molecular scaffolding and a micro-envi-
ronment that includes growth factors (1, 46). Engineering
analysis of the forces active in the vessel is complex (1, 5-7).
This study provides the first evidence for the cell biological
mechanisms by which the vessel induces changes in tissue
specific gene and protein expression.
There are two possible explanations why the rotating wall
vessel induces an order of magnitude more expression of the
renal toxinreceptors cubulin and megalin than stirred fermen-
tor culture. First, there are significant differences in the
degree of shear stress induced. The rotating wall vessel
induces 0.5-1.0 dynes/cm2 shear stress (1), while stirred fer-
mentors induce 2-40 dynes/cm2 depending on design and
rotation speed (1, 5, 46). This degree of stress damages or kills
most epithelial cells (1, 5,46). Second, impeller trauma in the
stirred fermentor is absent in the rotating wall vessel. This
condition explains why there was far more cubulin and mega-
lin induced in renal cultures in the rotating wall vessel culture
than a stirred fermentor, and both receptors were not detect-
able in conventional 2-dimensional culture.
Rotating wall vessel culture induced changes in a select set
of genes, as evidenced by the genetic differential display gels
and two-dimensional protein gel analysis. For example,
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erythropoietin production is controlled by a shear stress ele-
ment which mediates changes observed during graded gravi-
tation sedimentation shear. 1-a-hydroxylase activity is main-
tained and increased in both renal cortical epithelial cells and
5 human embryonic kidney cells, wherein the induction of the
enzyme (1-a-hydroxylase) converts 25-hydroxy-vitamin D3
to the active 1,25-dihydroxy-vitamin D 3 form. The exemplary
embodiment of the present invention is the first demonstra-
tion of a process for production of molecules including hor-
10 mones and other biomolecules induced by shear stress and
other forces. The mechanistic information can be interpreted
from knowledge of the pattern of response and distribution of
certain gene products.
Megalin and cubulin represent the first pattern of change,
15 as these proteins are restricted in distribution to renal cortical
tubular epithelial cells. The increase in megalin mRNA and
protein and cubulin protein expression is therefore unequivo-
cal evidence for changes in the epithelial cells. This result
provides an important new tool for studies of nephrotoxicity.
20 Long suspected to play a role in renal toxicity, the tissue
restricted giant glycoprotein receptors megalin and cubu-
lin have recently been shown to be receptors for common
nephrotoxins. Megalin is a receptor for polybasic drugs such
as the aminoglycoside antibiotic gentamicin (48) and vitamin
25 D binding protein (51), and cubulin is the receptor for vita-
min-1312 intrinsic factor (52). Although these receptors are
expressed by transformed placental cells in culture (9, 43),
there is currently no renal model expressing these markers for
toxicology investigations (53). Culture within a rotating wall
30 vessel provides a fresh approach to expression of renal spe-
cific markers in culture for study on the pharmacology, bio-
chemistry and toxicology which define the unique properties
and sensitivities of renal epithelial cells.
The second pattern of change is represented by villin.
35 Message for the microvilli protein villin increases in the
rotating wall vessel in the first day of culture, and soon ref-
ormation of microvilli was observed. A decoy matching the
nuclear binding motif of a putative shear stress response
element failed to induce similar changes. Although the pro-
40 moter for villin has not been cloned, this result suggests the
changes in villin were induced by other transcription factors
which may be due to shear stress or other stimuli in the
bioreactor. Villinis also restricted to brush border membranes
such as renal proximal tubular cells, or colonic villi (54-55).
45 The observed increases in villin message resolved after 16
days of rotating wall vessel culture.
Magnesium dependent superoxide dismutase represents a
third pattern of response: a mitochondrial enzyme, ubiquitous
in distribution, modulated by the classic shear stress response
50 element in endothelial cells (56 57). Magnesium dependent
superoxide dismutase message decreased early in the first day
of rotating wall vessel culture, and this condition was persis-
tent after 16 days in culture. These changes were confirmed
when magnesium dependent superoxide dismutase was iden-
55 tified as suppressed in the differential display analysis of gene
changes, and Northern blot confirmation was performed. A
decoy for the classic shear stress response element induced an
increase in magnesium dependent superoxide dismutase
(MnSOD), which indicates that similar changes to the rotat-
60 ing wall vessel can be induced by the use of genetic decoys.
Thus, the biological process of genetic induction by defined
shear stress elements can be produced by multiple means
including genetic decoys or use of the rotating wall vessel.
Other shear stress response element dependent genes, specifi-
65 cally, intercellular adhesion molecule I (ICAM) and vascular
cell adhesion molecule (VCAM) had changes in the rotating
wall vessel opposite to magnesium dependent superoxide
US 7,972,821 B2
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dismutase, mirroring observations made during flow induced
stress in endothelial cells (56-57). This result provides three
lines of evidence consistent with a role for shear stress as one
mediator of genetic changes induced in the rotating wall
vessel.
Differential display of the genes activated and deactivated
under rotating wall vessel culture conditions showed rotating
wall vessel culture was associated with decreased expression
of manganese dependent superoxide dismutase mRNA and
increased expression of interleukin-1 b gene mRNA. This
greatly extends and brings together previous observations on
the interactions of stress, manganese dependent superoxide
dismutase expression and interleukin-1. Topper et al. reported
an oppositely directed effect, i.e., differential display of vas-
cular endothelial cells exposed to high stress demonstrates
increased manganese dependent superoxide dismutase gene
expression (57). Other direct evidence links superoxide dis-
mutase and interleukin-1 as increases in manganese superox-
ide dismutase levels and decreases in interleukin-1 levels in
HT-1080 fibrosarcoma cells (58). In more indirect evidence,
overexpression of mitochondrial manganese superoxide dis-
mutase promotes the survival of tumor cells exposed to inter-
leukin-1 (59). The exemplary embodiments herein present
direct evidence that modest shear stress decreases magne-
sium dependent superoxide dismutase in association with an
inverse effect on interleukin-1.
The results herein demonstrate internal consistency. The
changes in magnesium dependent superoxide dismutase were
observed on differential display, confirmed by Northern blot
analysis, and matched responses were detected by RT-PCR.
Megalin demonstrated matched changes in RT-PCR gene and
protein expression. Changes in villin observed by RT-PCR
were associated with dramatic reformation of microvilli, in
which villin is a major structural protein. Although semi-
quantitative RT-PCR is prone to inherent variation due to the
massive amplification of signals, the use of multiple controls
which remain unchanged (b-actin, GAPDH and 18S), and
experimental confirmation that reactions were linearly
related to cDNA concentration, minimizes these problems.
The internally consistent findings by other methods strongly
suggests this RT-PCR data is valid.
Study of the mechanisms of action of the rotating wall
vessel to induce gene and protein expression during cell cul-
ture has been hampered by nomenclature. First, the attach-
ment of the moniker "simulated microgravity", based on
engineering analysis of boundary conditions, clouds intuitive
analysis of the cell biology as there is no cellular equivalent
for this term (1, 6 7). Similarly, the reduced shear stress in the
rotating wall vessel compared to stirred fermentors leads to
the term "reduced shear stress culture" (1), whereas there is
increased shear stress compared to conventional 2-dimen-
sional culture (1, 5). As cell aggregates remain suspended in
the rotating wall culture vessels, gravity is balanced by an
equal and opposite force. Engineering arguments on the rela-
tive contributions of fluid shear, drag, centrifugal force,
Coriolis motion, and tangential gravity-induced sedimenta-
tion are themselves tangential to the cell biology. Several
lines of evidence are documented to indicate that shear stress
responses are one of the components of the biological
response. This research opens the door for analysis of other
biological response mediators in the vessels and for investi-
gation as to whether unloading of gravity plays as big a role as
the oppositely directed balancing forces.
Using the rotating wall vessel as a tool, data described
herein provide the first evidence that shear stress response
elements, which modulate gene expression in endothelial
cells, are also active in epithelial cells, although other inves-
tigators failed to see an effect of shear stress on epithelial
cells. The present invention demonstrates that epithelial cells
have shear stress response elements and change gene expres-
20
sion in response to physical forces, including but not limited
to sedimentational shear stress. As the rotating wall vessel
gains popularity as a clinical tool to produce hormonal
implants, it is desirable to understand mechanisms by which
5 it induces genetic changes (10, 60) if necessary to prolong the
useful life of implants. Several lines of evidence are provided
that shear stress response elements are the first mechanism
identified by which the rotating wall vessel induces genetic
changes. Using a putative endothelial cell shear stress
10 response element binding site as a decoy, the role of this
sequence in the regulation of selected genes in epithelial cells
was validated. However, many of the changes observed in the
rotating wall vessel are independent of this response element.
It remains to define other genetic response elements modu-
lated during rotating wall vessel culture, and whether the
15 induced changes are secondary to the balancing forces, or
primarily related to unloading gravity.
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This application hereby incorporates by reference the 	 CTGAGACCGA TATCGGTCTC AG
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SEQUENCE LISTING
<160> NUMBER OF SEQ ID NOS: 1
<210> SEQ ID NO 1
<211> LENGTH: 22
<212> TYPE: DNA
<213> ORGANISM: Unknown
<220> FEATURE:
<223> OTHER INFORMATION: Single-stranded, Linear Topology, Hypothetical:
no; Antisense: yes
<300> PUBLICATION INFORMATION:
<302> TITLE: Production of Functional Proteins: Balance Of Shear Stress
and Gravity
<310> PATENT DOCUMENT NUMBER: 6,730,498
<311> PATENT FILING DATE: 1998-04-08
<312> PUBLICATION DATE: 2004-05-04
<400> SEQUENCE: 1
ctgagaccga tatcggtctc ag 	 22
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What is claimed is:
1. A method of producing active 1,25-dihydroxy vitamin
D3 comprising the steps of:
isolating at least one renal cell;
placing said at least one renal cell into a rotating wall vessel 5
containing culture media and a cell culture matrix;
culturing said at least one renal cell in the rotatine wall
vessel to produce three-dimensional cell aggregates and
a supernatant; and io
collecting 1,25-dihydroxy vitamin D3 from the superna-
tant.
2. A method of producing active 1,25-dihydroxy vitamin
D3 comprising the steps of:
24
isolating a natural mixture of cells from a renal cortex and
isolating purified renal proximal tubular cells;
placing said isolated natural mixture of cells from a renal
cortex and said isolated purified renal proximal tubular
cells into a rotating wall vessel containing culture media
and a cell culture matrix;
co-culturing said isolated natural mixture of cells and said
isolated purified renal proximal tubular cells in the rotat-
ing wall vessel to produce three-dimensional cell aggre-
gates and supernatant; and
collecting 1,25-dihydroxy vitamin D3 from the superna-
tant.
